The Biotechnology Innovation Organization is joining the legal fight against the Trump administration’s pilot program aimed at aligning drug prices in Medicare with prices charged in peer countries. BIO and two California-based biotech trade groups filed a complaint Friday in the U.S. District Court for the Northern District of California asserting that the Global Benchmark for Efficient Drug Pricing demonstration, known as GLOBE, oversteps Medicare’s statutory authority. The complaint seeks to halt the model.
The Centers for Medicare and Medicaid Services did not immediately respond to a request for comment.
Source: statnews.com · Image: Naitō Museum of Pharmaceutical Science and Industry 20210529 10 by 先従隗始, CC0, via Wikimedia Commons
Explore deeper: the API & FDF Intelligence database is more than a directory.
It combines global coverage of APIs, excipients, and finished dosage forms with real market intelligence.
You’ll find:
– Price ranges for APIs, excipients, and formulations.
– DMF, CEP, and GMP compliance status.
– Manufacturer portfolios by product and geography.
– Direct contacts for every producer and FDF holder, ready for outreach.
Instead of scattered spreadsheets and endless searches, the entire picture is a few clicks away. Subscription starts at an accessible rate — see how much time and budget you save by centralizing everything.
Start your 7-day trial and see what the database can do →
Start your 7-day trial and see what the database can do →
